Learn how to read Fluciclovine F18 scans in the biochemical recurrent prostate cancer patient from the experts. Register now to join us at the SNMMI 2017 Annual Meeting for a 3-hour, hands-on, case review training session. Don’t miss out this great opportunity to learn how to accurately interpret the newly approved agent, Fluciclovine F18. Please note: space is limited to the first 100 registrants. Date/Time: Friday, June 9, 2017; 12:00-3:00 pm Location: Hyatt Regency Denver at the Colorado Convention Center, Denver, Colorado